CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Shares withheld for taxes Chief Operating Officer gave up 7,649 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 67,682 shares (to pay taxes)
- 4 Grant or award Chief Accounting Officer acquired 3,316 shares (grant or award)
- 4 Grant or award SVP, Chief of Staff acquired 6,468 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 12,758 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 10,622 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 12,758 shares (grant or award)
- 4 Grant or award President and CEO acquired 114,828 shares (grant or award)
- 4 Shares withheld for taxes Chief People Officer gave up 1,912 shares (to pay taxes)
- 10-K Report Annual Report
- 4 Shares withheld for taxes SVP, Chief of Staff gave up 2,697 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 1,016 shares (to pay taxes)
- 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Chief Financial Officer gave up 12,230 shares (to pay taxes)
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Scientific Officer gave up 417 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 29,578 shares (to pay taxes)
- 4 Grant or award Director acquired 22,816 shares (grant or award)
Page 9 of 104 · 2,077 filings